Arredondo GJL, Soriano BD, Solórzano SF, Arbo SA, Coria JR

Idioma: Español
Referencias bibliográficas: 19
Paginas: 100-106
Archivo PDF: 84.91 Kb.

RESUMEN

En nuestro país, las infecciones del tracto urinario (UTIs) son las más comunes. Los grupos etarios más afectados son los niños, las mujeres sexualmente activas, embarazadas y adultos mayores. El agente causal más frecuente es Escherichia coli y presenta cambios en sus perfiles de sensibilidad y resistencia. Se realizó un estudio multicéntrico en la ciudad de México de cepas de Escherichia coli, aisladas de orina de pacientes con diagnóstico de infección aguda de vías urinarias bajas.

REFERENCIAS (EN ESTE ARTÍCULO)

1. National Institutes of Health. The national kidney and urologic diseases advisory board. 1990 Long-Range Plan/Window on the 21st Century. Bethesda, Md: National Institutes of Health 1990; 90:583.

2. Patton JP, Nash DB, Abrutyn E. Urinary Tract Infection: economic considerations. Med Clin North Am 1991; 75: 495-513.

3. Le Saux N, Pham BA, Moher D. Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections in children: a systematic review. CMAJ, 2000; 163(5)523-9.

4. Grupta K, Scholes D, Stamm W: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999; Feb 281(8):736-738.

5. Hellerstein S. Urinary tract infections: old and new concepts. Pediatr Clin North Am. 1995; 42:1433-5.

6. Prais D, Straussberg R, Avitzur Y, Nussino Vitch M, Harel L, Amir J. Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection. Arch Dis Child 2003, 88, 215-8.

7. Grupta K, Stamm WE. Urinary tract infections. ACP medicine 2005; (c) 2005 web mD inc.

8. Lorente Carin JA, Placer Santos J, Salvado Costa M, Segura Alvarez C, Gelabert-Mas A. Antibiotic resistance transformation in community-acquired urinary infections. Rev Clin Esp 2005; jun 205(6):259-64.

9. O’ Donnell JA, Gelone SP, Abrutyn E. Selecting drug regimens for urinary tract infections: current recommendations. Infect Med. 2002;19(1):14-22.

10. Sahm DF, Thernsberry C, Kelly LJ, Jones ME, Karlowsky JA. In vitro activities of commonly used antibiotics against prevalent uropathogens: implications for empiric therapy. Infect Urol. 2001; 14(3):59-67.

11. Warren JW, Abrutyn E, Hebel JR et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Antimicrob Agents Chemother. 1991; 35:1479-83.

12. Fritzsche R, Ammann A, Droz S, Bianchetti MG, Aebi C. Changes in antimicrobial resistence of Escherichia coli causing urinary tract infections in hospitalized children. Eur J Clin Microb Infect Dis. 2005; 24: 233-235.

13. Wright SW, Wrenn KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary tract coliform isolates. J Gen Intern Med. 1999; 14: 606-609.

14. Wright SW, Wrenn KD, Haynes ML et al. Prevalence of risk factors for multidrug resistant uropathogens in patients. Am J. Emerg Med. 2000; 18:143-146.

15. Raka L, Mulliqui-Osmani G, Berisha L, Begolli L, Omeragi S, Parsons L, Sallinger M, Jaka A, Kurti A, Jakupi X. Etiology and susceptibility of urinary tract isolates in Kosovo. Int J Antimicrob Agents 2004; 2351: S2-S5.

16. Arredondo-García JL, Figueroa-Damián R. Estado actual de las infecciones de las vías urinarias. Editorial Ferlini, Rosen y Asociados, S.A. de C.V. 2002.

17. Calderón J, Arredondo JL, Olvera J, Echaniz G, Conde C, Hernández P. Cistouretritis aguda durante la gestación. Ginecol Obstet Méx 1989; 47: 47-63.

18. José Luis Arredondo-García, Ricardo Figueroa Damián, Alejandro Rosas, Arturo Jáuregui, Mauricio Corral, Alexis Costa, Roberto Mauricio Merlos, Antonio Ríos-Fabra, Carlos F. Amábile-Cuevas, Gerardo M. Hernández- Oliva, Jorge Olguín, Oscar Cardeñosa-Guerra. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. Journal of Antimicrobial Chemotherapy 2004; 54: 840-843.

19. Chairperson: Lindsay E. Nicolle, MD, FRCP; CME Planning/Steering Committee: Thomas M. Hooton, MD; Wanda K, Jones, DrPH, Lindsay, E. Nicolle, MD, FRCP; Carol Fisher. Managing Acute Uncomplicated Cystitis in the Era of Antibiotic Resistance. September 30, 2004. www.medscape.com/viewprogram/2634